|
Molecular and Clinical Studies of Primary Immunodeficiency diseases Clinical Trials Resources presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, visits or professional assistance with a real medical. We aren't doctors. Always consult your mD about Molecular and Clinical Studies of Primary Immunodeficiency diseases conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Molecular and Clinical Studies of Primary Immunodeficiency diseases Clinical research trials and Molecular and Clinical Studies of Primary Immunodeficiency diseases health trials occur in a lot of of places throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new does drugs. The role of the studies / projects is to resolve certain human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector corporations to detect remedies for all varieties of circumstances, such as Molecular and Clinical Studies of Primary Immunodeficiency diseases. Molecular and Clinical Studies of Primary Immunodeficiency diseases Clinical Trials and other clinical trials allow volunteers to obtain health treatment choices before they are available to the general public. Most times the human subjects recieve professional assistance for free of charge, and every now and again they are paid for their time. Sometimes there is a cost for a Molecular and Clinical Studies of Primary Immunodeficiency diseases clinical trial. Human subjects frequently get the finest healthcare available for their Molecular and Clinical Studies of Primary Immunodeficiency diseases condition. Risks are a reality, however, and may include extra or frequent physician visits, medical dangers (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with strict guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "M" Clinical Trials Conditions > Molecular and Clinical Studies of Primary Immunodeficiency diseases  Molecular and Clinical Studies of Primary Immunodeficiency diseases
Molecular and Clinical Studies of Primary Immunodeficiency diseases
For Condition: Immunologic Deficiency Syndrome
Status: Recruiting
Sponsor(s): National Human Genome Research Institute (NHGRI) ,
Synopsis: This study will try to identify mutations in the genes responsible for primary immunodeficiency disorders (inherited diseases of the immune system) and evaluate the course of these diseases in patients over time to learn more about the medical problems they cause. The immune system is composed of various cells (e.g., T and B cells and phagocytes) and other substances (complement system) that protect the body from infections and cancer. Abnormalities in the gene(s) responsible for the function of these components can lead to serious infections and other immune problems. Patients with Wiskott-Aldrich syndrome, adenosine deaminase (ADA) deficiency, Janus Associated Kinase 3 (JAK3) deficiency, common variable immunodeficiency (CVID) and other immunodeficiencies may be eligible for this study. Participants will undergo a medical and family history, physical examination, and additional procedures and tests that may include the following: 1. Blood tests for: routine laboratory studies (i.e. cell counts, enzyme levels, electrolytes, etc.); HIV testing; immune response to various substances; genetic testing; and establishment of cell lines to maintain a supply of cells for continued study 2. Urine and saliva tests for biochemical studies 3. Skin tests to assess response to antigens such as the viruses and bacteria responsible for tetanus, candida, tuberculosis, diphtheria, chicken pox, and other diseases. 4. Skin and lymph node biopsies for tissue and DNA studies 5. Chest X-ray, CT scans, or both to look for cancer or various infections. 6. Pulmonary function test to assess lung capacity and a breath test to test for H. pylori infection. 7. Dental, skin and eye examinations. 8. Treatment with intravenous immunoglobulins or antibodies to prevent infections. 9. Apheresis for collecting white blood cells to study cell function. In this procedure, whole blood is collected through a needle placed in an arm vein. The blood circulates through a machine that separates it into its components. The white cells are then removed, and the red cells, platelets and plasma are returned to the body, either through the same needle or through a second needle placed in the other arm. 10. Bone marrow sampling to study the disease. A small amount of marrow from the hipbone is drawn (aspirated) through a needle. The procedure can be done under local anesthesia or light sedation. 11. Placental and umbilical cord blood studies, if cord blood is available, to study stem cells (cells that form blood cells). Information gained from this study may provide a better understanding of primary immunodeficiencies, leading to better diagnosis and treatment. In addition, study participants may receive medical and genetic counseling and may be found eligible for other NIH studies on these diseases.
Details: The purpose of this study is to study patients with primary immunodeficiency disorders with the goal of contributing to both the clinical and molecular understanding of this heterogeneous group of inherited diseases. Clinical issues to be addressed will include disease manifestations and evolution, as well prevention and management of medical problems. Patients with diseases of known molecular basis (including Wiskott-Aldrich syndrome, ADA deficiency, JAK3 deficiency and other syndromes) will be genotyped in order to investigate phenotype-genotype correlation. Patients with disease of unknown or incomplete genetic characterization (e.g. Common Variable Immune Deficiency, CVID) will be studied with hopes of contributing to the identification of specific genes responsible for disease. Studies of fresh cells, cell lines and tissue samples will be performed to help characterize the patient's syndrome as well as to test the efficacy of genetic correction when available. The outcome we seek is to improve our knowledge of the molecular basis, clinical presentation and evolution of primary immunodeficiency diseases and to collaborate to maintain or improve the health status of our patients. It is anticipated that additional protocols will be generated from preliminary data gathered in this umbrella study.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Patients with a clinical history or signs and symptoms suggestive of a primary immune deficiency syndrome may be referred by their physician or self referred for inclusion in this study. EXCLUSION CRITERIA: Inability to provide informed consent. Patients infected with the Human Immunodeficiency Virus before enrollment.
Total Enrollment: 120
Location and Contact Information:
National Human Genome Research Institute (NHGRI) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 000209; 00-HG-0209
Study Start Date: September 24, 2000
Record last reviewed: August 31, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00006319
Other Immunologic Deficiency Syndrome Studies:
1. Investigation of the Human Immune Response in Normal Subjects and Patients with Disorders of the Immune System and Cancer
2. Immune Regulation in Patients with Common Variable Immunodeficiency and Related Syndromes
3. In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
4. Genetic Analysis of Immune Disorders
5. Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected Patients
Related Studies:
Other Immunologic Deficiency Syndrome Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Molecular and Clinical Studies of Primary Immunodeficiency diseases
|
|
|
|
|
|
|
|
